Lecture Details - Overview

View all Online CME

Continuing Education Information

Physicians' Education Resource is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Molecular Profiling and Decision Making in Breast Cancer: Treatment Decision Tools

Release Date: October 10, 2008| Expiration Date: October 10, 2009
Oct 10, 2008, Online Learning Series Program 1

Lecture Overview

Molecular Profiling and Decision Making in Breast Cancer: A Continual Online Learning Series is designed to provide sustained on-line learning for oncologists and other health care providers involved in the diagnosis and treatment of breast cancer.  In the area of molecular profiling the recent emergence of commercially available gene profiling tools, coupled with the variable degree of benefit balanced against the short and long term effects of chemotherapy creates a pressing educational need for clinicians.

This educational activity is intended for medical and surgical oncologists who counsel patients on therapeutic decisions following surgery for early-stage breast cancer. Other physicians, including pathologists, radiation oncologists, primary physicians, and other health care providers, including nurses, pharmacists, and others who care for patients with breast cancer, are also invited to participate. No specific skills or knowledge other than a basic training in oncology is required for successful participation in this activity.

At the conclusion of this activity, you should be able to:

  • Discuss molecular heterogeneity of breast cancer and the relationship of gene-based molecular profiles to clinical outcomes
  • Compare and contrast different molecular profiling assays and their ability to provide prognosis of patients with early stage breast cancer
  • Apply molecular profiling in patient decision-making in defined clinical scenarios
  • Describe the advantages and limitations of different molecular profiling assays and indications for participation in clinical trials designed to further evaluate their utility in decision-making for early stage breast cancer

Instructions for Participation

  • Read the following information before beginning the educational activity.
  • Complete the pretest.
  • View and study all video presentations for the didactic portion and case #1.
  • Complete the posttest.
  • Posttest questions #2 and #5 must be answered correctly to receive a certificate.
  • Answer the evaluation questions.
  • After successful completion of the posttest and evaluation, you will receive your certificate of credit online.
View the Activity
You will be asked to login
or create an account.

Educational Grants

An educational grant for this activity was provided by:


  1. Agendia